Medicine
Z. Levi, N. Abu-Freha, D. Boltin, Maya Aharoni Golan, T. Konikoff, Orly Sneh Arbib, R. Belfer, S. Eizenstein, A. Vilkin, Shiri Kusnir, Adi Turgeman, Tanya Babich, Moshe Leshno, A. Flugelman, H. Edelman-Klapper, E. Half-Onn
2026.3.1HELICOBACTER
Abstract
We evaluated the association between Fecal Immunochemical Test (FIT) results and the risk of gastroesophageal cancer (GEC) in a matched cohort, as well as the cost‐effectiveness of a one‐time esophagogastroduodenoscopy (EGD) for individuals who tested FIT‐positive.
Citation format
LEVI, Z., et al. The association of a positive fecal immunochemical test with the risk of gastroesophageal cancer: An age‐sex‐h. pylori exposure matched cohort study and cost‐effectiveness analysis. HELICOBACTER, 2026, 31(2): e70120.